We have used this antibody in our recent studies on HSPA2 expression and function in epidermal keratinocytes and NSCLC cells [18,19]; it was also used in one study aimed at evaluating potential value of HSPA2 as a prognostic biomarker in pancreatic adenocarcinoma [14]. Here, HSPA2 is linked to pancreatic adenocarcinoma.